NEWS & ANALYSIS

Natural aesthetic takes over Bollywood in 2024

Bollywood continues to lead global beauty trends, with 2024 marking a shift towards more subtle, natural-looking cosmetic enhancements. The global trend of embracing individuality is being followed by actors and actresses, who are increasingly choosing procedures that prioritise refinement over transformation.

Among the top procedures are rhinoplasty, breast augmentation, and advanced 4D VASER liposuction. Rhinoplasty remains a favourite for facial balance, while liposuction and tummy tucks help stars achieve contoured physiques. Jawline enhancements and chin augmentations, often combined with rhinoplasty, are gaining popularity for creating a balanced facial profile. Facelifts such as surgical and nonsurgical remain a go-to solution for those combating ageing signs. Fat grafting is also in high demand, offering a natural, risk-free way to enhance facial and body contours using the patient’s own fat.

Bollywood is known for its unique aesthetic and commitment to artistic perfection. This is seen in its growing desire for custom-made, understated modifications, which globally impacts beauty standards.

Kosmoderma Clinic brings LPG Endermologie to India

Kosmoderma Clinic has launched the LPG endermologie Cellu M6 Alliance, a groundbreaking technology for non-invasive body contouring and facial rejuvenation, at its Bengaluru branch. This advanced system addresses stubborn fat, cellulite, and skin laxity while promoting natural collagen production for enhanced skin firmness and improved circulation.

Dr Chytra Anand, Founder, Kosmoderma, highlights this innovation as a gamechanger for body toning, facial contouring, and post-workout healing, offering visible, long-lasting results with no downtime. The treatment is favoured by celebrities like Gwyneth Paltrow and Jennifer Lopez for its ability to reduce cellulite and sculpt the body.

Kosmoderma’s collaboration with LPG endermologie marks a significant milestone in India’s aesthetic dermatology market, bringing cutting-edge technology that meets the growing demand for noninvasive, effective solutions for both body and face. This launch further solidifies Kosmoderma’s position as a leader in advanced dermatology and aesthetic care.

Urfi Javed sparks dialogue on cosmetic choices

Social media influencer Urfi Javed’s recent decision to pursue silicone breast implants, despite being advised of potential risks, has raised concerns within the medical community. Dr Rohan Khandelwal, oncologist and head of the Breast Centre at CK Birla Hospital, has reportedly warned that such messaging can mislead young women and downplay the health risks of silicone implants.

Contrary to popular belief, silicone implants are not without complications. Common risks include infections, capsular contracture (painful scar tissue hardening), and implant rupture. Moreover, breast implant illness (BII) is linked to symptoms like fatigue and joint pain. Also, implants often require replacement every 10-15 years, leading to potential health risks from repeated surgeries. Alternatives such as fat grafting uses the patient’s own tissue for safer, more natural results. There is a need for informed decision-making and choosing qualified surgeons for any cosmetic procedure.

High satisfaction rates in Adam’s apple surgery

A recent study published in Plastic and Reconstructive Surgery Global Open reveals high patient satisfaction rates for ‘Adam’s apple’ reduction surgery, known medically as aesthetic chondrolaryngoplasty. The study by Dr Jeffrey H Spiegel and his team at Boston University Medical Centre highlights the need for plastic surgeons to carefully balance cosmetic results with the risk of irreversible voice changes.

The procedure, primarily sought by transgender women as part of facial feminisation, involves reducing the prominence of the thyroid cartilage. Dr Spiegel has performed over 600 such surgeries since 2006, with 60 per cent of patients reporting they were “very” or “completely” satisfied with their neck appearance. Notably, 55 per cent felt their results were optimal, and none experienced long-term voice alterations.

The introduction of a new seven-item questionnaire allows surgeons to better assess the physical and emotional impacts of the surgery, equipping them to set realistic expectations for future patients.

Dr Amalia Tsiatoura shines at FADS Congress

At the recent 8th World Congress of the Face Aesthetic Dermatologists Society (FADS) in New Delhi, Dr Amalia Tsiatoura, Dermatologist-Venereologist and Scientific Director of Cosmetic Derma Medicine, shared her expertise on non-surgical full-face rejuvenation. This event, held from September 27-29, gathered leading professionals in dermatology, with Dr Amalia, recognised as a top speaker for her innovative clinical work. Her presentation focused on “Neck Rejuvenation with a Combination of HIFU, Polynucleotides (PDRN), and Botulinum Toxin A,” showcasing a study of 49 patients. Dr Amalia demonstrated how combining HighIntensity Focused Ultrasound (HIFU), PDRN, and botulinum toxin A results in significant improvements in neck skin rejuvenation. This minimally invasive approach targets the ageing neck and lower face while enhancing the effectiveness and longevity of the treatments.

Emcure Pharma enters dermatology with Emcutix Biopharmaceuticals

Emcure Pharmaceuticals has announced the formation of Emcutix Biopharmaceuticals, a wholly-owned subsidiary dedicated to dermatology. The new venture will be led by G Sathya Narayanan, a seasoned professional with over 30 years of experience in the dermatology sector, including his previous role as Managing Director of Galderma for South Asia.

Emcutix aims to expand Emcure’s portfolio by offering innovative solutions for skin health, addressing both therapeutic and aesthetic needs in the Indian market. This new entity will integrate Emcure’s existing dermatology business and focus on building a differentiated product portfolio, including first-time launches designed to meet the specific needs of the Indian market.

To this, Satish Mehta, CEO of Emcure Pharmaceuticals, reported has noted the significant growth in India’s dermatology market and affirmed Emcure’s strong position to address its changing needs. G. Sathya Narayanan, now CEO of Emcutix, has reported shared his enthusiasm for advancing impactful dermatology solutions that will benefit healthcare providers, patients, and consumers alike, building on Emcure’s commitment to innovation in skin health.

Dr Anuradha Kakkanatt Babu awarded ‘Dermatologist of the Year’

In a remarkable achievement, Dr Anuradha Kakkanatt Babu has been awarded the title of ‘Dermatologist of the Year’ at the Economic Times Healthcare Awards 2024. This prestigious recognition highlights her outstanding contributions to dermatology and her unwavering commitment to advancing skin health and patient care. Dr Kakkanatt Babu stands out for her innovative treatment approaches, dedication to patient education, and impactful research. Her unique ability to blend compassion with clinical expertise has transformed countless lives, earning her respect from peers and gratitude from patients alike. The Aster family proudly celebrates this accolade, reflecting their commitment to excellence in healthcare and her pivotal role as a mentor and advocate within the community. Dr Kakkanatt Babu’s hard work and passion continue to inspire those around her, setting a high standard for quality care in dermatology.

IADVL hosts Aesthetic Injectables Workshop in J&K

The Indian Association of Dermatologists, Venereologists, and Leprologists (IADVL) Jammu and Kashmir Branch, in partnership with Government Medical College (GMC) Srinagar, recently organised a milestone workshop titled “Excellence in Aesthetic Injectables.” Led by Prof Iffat Hassan, Principal/Dean of GMC Srinagar, as Patron, and Dr Yasmeen Jabeen, HOD Dermatology and President of IADVL J&K, as Chair, the workshop aimed to elevate aesthetic injectable practices in the region.

National and local experts, including Dr Rajat Kandhari, Dr Rashmi Sharma, Dr Sonali Langar, Dr Nishita Ranka, Dr Imran Majid, and Dr Syed Mubashir, led sessions on advanced techniques and patient-centred care. The event saw active participation from dermatology heads across institutions, including SKIMS Medical College, GMC Baramulla, and senior valley dermatologists. The programme covered cutting-edge techniques in toxins and fillers, focusing on safety, efficacy, and patient satisfaction. The workshop included hands-on sessions with 60 participants and provided treatments to 15 patients, marking a significant step in advancing aesthetic dermatology practices in J&K.

Global aesthetic industry to hit $50 billion by 2031

The global medical aesthetics market is experiencing robust growth, driven by increasing consumer demand for non-invasive cosmetic procedures and technological advancements. Valued at $19.41 billion in 2023, the market is projected to reach $50.17 billion by 2031, growing at a CAGR of 12.60 per cent. This surge is fueled by innovations in treatments like injectables, laser therapies, and body contouring procedures, along with a rising preference for personalised, minimally invasive options. Key trends include the growing demand for injectable treatments, such as botulinum toxin, and laser systems offering effective results with minimal downtime. The rise of medical spas and aesthetic clinics has made these services more accessible, while AI and advanced imaging techniques are enhancing patient experiences and outcomes.

The market is also seeing a shift in consumer behaviour, with increasing disposable income allowing more individuals to invest in aesthetic enhancements. Moreover, the sector’s growth is propelled by the increasing awareness of cosmetic treatments, supported by influencers and social media platforms. However, challenges remain, including a shortage of trained professionals and the high cost of procedures. Despite these obstacles, the market’s future looks promising, with significant opportunities for growth, particularly in emerging markets like India, Brazil, and South Africa.

Over 500 experts unite at Emirates Dermatology Conference 2024

The 8th Emirates Dermatology Society Annual Conference 2024 successfully concluded at the InterContinental Dubai – Festival City Hotel, bringing together over 500 dermatologists, cosmetologists, and laser specialists from around the world. During the threeday event, Dr Muna Al Murrawi, President of the Emirates Dermatology Society and Chair of the Conference, guided attendees through more than 85 expert-led sessions on dermatology and aesthetics. The scientific programme featured workshops covering key topics such as hair and nail disorders, acne, skin cancer, and women’s health in dermatology. Notably, the conference delved into the latest advancements in hair transplantation, skin tumour treatments, and the growing role of laser therapies in treating skin conditions like pigmentation, burns, varicose veins, tattoos, psoriasis, vitiligo, eczema, and fungal infections.

As one of the largest events of its kind in the Middle East, the conference aimed to elevate awareness of international medical practices and highlight proven treatment success stories. The accompanying exhibition, with over 29 local and international companies, showcased the latest technologies and devices in skin disease diagnosis, laser treatments, and cosmetic procedures. Speakers from the USA, UK, Mexico, Spain, Italy, Singapore, India, Saudi Arabia, Bahrain, Egypt, and the UAE shared their insights during the event.

Galderma’s Sculptra ® celebrates 25 years with breakthrough data

Galderma marks the 25th anniversary of Sculptra® with new data and recent approvals, strengthening its leadership in regenerative aesthetics. Sculptra, the first proven treatment to stimulate collagen and elastin production, continues to evolve, with its unique poly-Llactic acid (PLLA-SCA™) formulation showing impressive regenerative properties.

New research presented at the American Society for Dermatologic Surgery Annual Meeting highlighted Sculptra’s efficacy in stimulating components of the extracellular matrix, including collagen and elastin, while reducing inflammation compared to other biostimulators. Data also revealed Sculptra’s role in adipocyte modulation, which may enhance skin quality, facial structure, and reduce signs of ageing.

Sculptra’s latest approval in China expands its reach in one of the fastest-growing aesthetics markets, building on its already strong global presence. With distribution in over 40 countries, Sculptra has transformed aesthetic treatments, addressing concerns such as volume loss, skin laxity, and facial ageing. Since its launch in 1999, initially to address facial wasting in AIDS patients, Sculptra has evolved into a versatile treatment, now offering longlasting improvements in skin firmness, radiance, and overall quality. Galderma’s commitment to advancing regenerative aesthetics positions Sculptra as a key solution for evolving patient needs across the world.

Aesthetic Society expands global alliance with 31 partners

The Aesthetic Society has reached a major milestone in expanding its Global Alliance Partners programme, now partnering with 31 renowned international aesthetic surgery organisations through Memorandum of Understanding (MOU) agreements. This expansion highlights the Society’s ongoing dedication to promoting worldwide collaboration in the field of aesthetic plastic surgery. The new Global Alliance Partners span across six continents, including organisations like the British Association of Aesthetic Plastic Surgeons, the Brazilian Society of Plastic Surgery, and the Korean Society for Aesthetic Plastic Surgery. These partnerships provide valuable opportunities for cross-cultural exchange, professional development, and educational growth for thousands of members globally.

The Aesthetic Society’s leadership, including President Dr Kiya Movassaghi and CEO Mark Theis, have traveled internationally to nurture these partnerships. Moreover, the efforts are supported by Dr Jamil Ahmad, Chair of the International and Global Alliances Committee, who is spearheading an educational initiative to leverage the global network through enhanced digital platforms and a new webinar series called GEMS. Looking ahead, The Aesthetic Society’s annual Aesthetic MEET® in Austin, TX, in March 2025, will offer a platform for global professionals to unite, with educational sessions and workshops to advance the speciality. The Society also provides international members with exclusive benefits, including discounted access to key publications and conferences.